Washington, DC–(ENEWSPF)–September 29, 2015. A monoclonal antibody therapeutic drug, a novel approach to treating patients with influenza, will advance in development with funding from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).
